Get the Stockscreener App
8.04
1.35%
-0.11
After Hours:
8.04
Linkers Industries Ltd stock is traded at $8.04, with a volume of 252.78K.
It is down -1.35% in the last 24 hours and up +0.00% over the past month.
Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.
See More
Previous Close:
$8.15
Open:
$8.16
24h Volume:
252.78K
Relative Volume:
3.23
Market Cap:
$105.73M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+60.48%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$7.72
$8.55
1-Week Range:
$4.90
$9.04
52-Week Range:
$4.17
$9.04
Linkers Industries Ltd Stock (LNKS) Company Profile
Name
Linkers Industries Ltd
Sector
Industry
Phone
-
Address
-
Compare LNKS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNKS
Linkers Industries Ltd
|
8.04 | 105.73M | 0 | 0 | 0 | 0.00 |
|
VRT
Vertiv Holdings Co
|
120.04 | 45.06B | 7.53B | 581.40M | 1.08B | 1.50 |
|
HUBB
Hubbell Inc
|
426.80 | 22.91B | 5.64B | 751.80M | 730.00M | 13.88 |
|
NVT
Nvent Electric Plc
|
69.55 | 11.46B | 3.82B | 576.00M | 581.30M | 3.41 |
|
AYI
Acuity Brands Inc
|
302.70 | 9.38B | 3.84B | 422.60M | 555.20M | 13.44 |
|
BE
Bloom Energy Corp
|
24.12 | 5.51B | 1.26B | -129.51M | -334.40M | -0.56 |
Linkers Industries Ltd Stock (LNKS) Latest News
ADCs: Leading With The Linker - BioProcess Online
Stock market news: Dream Vision surges 39.68%, Osaka Yuka up 37.72%, as Nippon Denkai drops 19.57% in mid-day volatility - Business Upturn
Linkers Industries LimitedClass A Ordinary Shares (LNKS) Latest News & Price - InvestorPlace
Linkers Industries announces pricing of initial public offering and listing on Nasdaq - MSN
U.S. IPO Weekly Recap: ServiceTitan Launches As Small Issuers Slip Through The IPO Window - Seeking Alpha
Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations - The Manila Times
Linkers Industries Limited Announced Closing of Initial Public Offering - EIN News
Linkers Industries Debuts on Nasdaq, Raises $7.6M in Wire Harness Manufacturing IPO - StockTitan
LNKS IPO NewsMalaysian cable manufacturer Linkers Industries prices downsized US IPO at the $4 low end - Renaissance Capital
Linkers Industries Limited Announces Pricing of Initial Public Offering and Listing on Nasdaq - The Manila Times
Linkers Industries Limited Prices 1.9M Share IPO at $4/sh - Investing.com Canada
LNKSLinkers Industries Limited Latest Stock News & Market Updates - StockTitan
TCL Electronics Approves Key Agreements at EGM - MSN
Top 10 startups in Manufacturing Tech in Saudi Arabia in Nov, 2024 - Tracxn
Antibody Drug Conjugates (ADC) Industry Report 2024 - GlobeNewswire
Antibody Drug Conjugates Industry Report (2024-2032) - GlobeNewswire
Antibody Drug Conjugates Market Size Potential to Reach USD 39 Billion by 2032 By IMIR Market Research Pvt. Ltd. - GlobeNewswire
OS Therapies Accepted Into Johnson & Johnson InnovationJLABS - Yahoo Finance
Antibody Drug Conjugates (ADCs) – Linker and Conjugation Technologies Market Report Scope - InsightAce Analytic
Era of ADCs: Pharma companies innovate to stand out in a buzzing market - Pharmaceutical Technology
Delocalized Orbitals over Metal Clusters and Organic Linkers Enable Boosted Charge Transfer in Metal–Organic Framework for Overall CO2 Photoreduction - Wiley Online Library
Textile Coatings Market Size, Share & Growth Report, 2030 - Grand View Research
Crosslinking Agent Market Size, Share & Growth Report 2030 - Grand View Research
Antibody Drug Conjugates Market Size to Reach USD 28.61 Bn by 2033 - BioSpace
Design of fusion enzymes for biocatalytic applications in aqueous and non-aqueous media - Frontiers
Biohaven Doses First Patient with its Novel Trop-2 Directed Antibody Drug Conjugate (ADC) BHV-1510 in Advanced or Metastatic Epithelial Tumors - PR Newswire
Pheon rides wave of ADC interest with $120M financing - BioPharma Dive
This Innovator Bridges Continents Through Sustainable Tourism Initiatives - Elle Canada
Initial Public Offering (IPO) News Live Feed - StockTitan
Antibody-Drug Conjugates (ADC) Market, Industry Trends, Pipeline Products and Challenges - GlobalData
KDDF bolsters the development of innovative cancer therapies - Nature.com
A smart lighting masterpiece: Nanoleaf Canvas review - Whats The Best
Manufacturing Challenges of Therapeutic Antibody–Drug Conjugates - BioProcess Insider
Fourteen biotech companies spearheading the antibody drug conjugate industry - Labiotech.eu
WuXi XDC Enters into Partnership with Multitude Therapeutics and HySlink Therapeutics, Novel Linker-Payload Technology Enabling Clients to Accelerate ADC Discovery and Development - PR Newswire
US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement - FiercePharma
Peptide Synthesis Market 2032: Size & Growth Forecasts - Vantage Market Research
The top 5 ADC startups favoured by venture capital investors - BioPharma-Reporter.com
Linkers Industries: LNKS IPO, IndustrialsMalaysian manufacturer and supplier of wire/cable harnesses. - Renaissance Capital
Samsung Bioepis, Intocell partner for ADC drug development - BioWorld Online
When to buy index-linked bonds - Investors Chronicle
ADC (Antibody Drug Conjugates) Markets, 2035 - Yahoo Finance
Antibody Drug Conjugates (ADC) Market worth $19.8 billion | MarketsandMarkets - PR Newswire
The Rise of Antibody–Drug Conjugates and Related Modalities: Innovations and Partnerships Lead the Way - BioProcess Insider
Thompson Street Capital Partner’s Vector Laboratories Acquires Quanta BioDesign - Business Wire
Vector Laboratories Acquires Quanta BioDesign to Continue Growth Strategy of Strengthening Development and Manufacturing Services for Life Science and Biopharma Customers - Business Wire
Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker - Frontiers
Revenge of the ADCs - The Medicine Maker
Enzymatic Bioconjugation: A Perspective from the Pharmaceutical Industry - ACS Publications
Companies are being called on to make their supply chains more resilient and transparent - global.toshiba
Next-generation ADCs: better oncology treatments through innovation - European Pharmaceutical Manufacturer
Linkers Industries Ltd Stock (LNKS) Financials Data
There is no financial data for Linkers Industries Ltd (LNKS). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.82%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):